CLINICAL TRIAL STUDY


Effect of M-Health Application: “Chicken LOF” (Low Fat in 90 Days) on Lipid Profile and Body Composition Among Dyslipidemia Healthcare Workers: A Randomized Controlled Trial



Suwadee Puntpanich1, *, Surasak Taneepanichskul1
1 College of Public Health Sciences, Chulalongkorn University, Bangkok, Thailand


Article Metrics

CrossRef Citations:
2
Total Statistics:

Full-Text HTML Views: 749
Abstract HTML Views: 424
PDF Downloads: 204
ePub Downloads: 161
Total Views/Downloads: 1538
Unique Statistics:

Full-Text HTML Views: 498
Abstract HTML Views: 261
PDF Downloads: 171
ePub Downloads: 134
Total Views/Downloads: 1064



Creative Commons License
© 2020 Puntpanich & Taneepanichskul.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at College of Public Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. Tel: (+66) 2-218-8194. E-mail: surasakta@yahoo.com


Abstract

Background:

Non-communicable disease has become a public health concern and is associated with an unhealthy lifestyle and aging.

Objective:

This study aimed to explore the effect of M-Health Application: “CHICKEN LOF” on lipid profile and body composition in healthcare workers with dyslipidemia.

Methods:

This study was a randomized controlled trial conducted on 80 full-time healthcare workers having dyslipidemia from Phuket City Hospital. Participants were randomly assigned by a computer generator into an intervention group and control group. The intervention group received “CHICKEN LOF”: M-Health Application and usual care, and the control group received only usual care. Outcomes were measured on days 30, 60, 90 and compared to baseline.

Results:

The mean age was 33.9 years in the intervention group and 33.2 years in the control group. The baseline characteristics were not statistically or significantly different. However, significant changes were observed in intervention group regarding total knowledge (p<0.001), total attitude (p=0.001), total practice (p<0.001), HDL-C (p=0.002), weight (p<0.001), BMI (p=0.001), body fat percentage (p=0.029), bone mass (p=0.030), BMR (p=0.032) and total body water (p=0.027). In pairwise comparison, a significant increase in knowledge, attitude and practice was found from the baseline to day 30, 60 and 90, respectively.

Conclusion:

In the present study, CHICKEN-LOF mobile application was found to be effective in terms of knowledge, attitude and practice, and contributed to improving lipid and body composition. This study suggests a longer term implementation to evaluate sustainability not only in the healthcare setting but also in the community.

Keywords: M-Health application, Lipid profile, Body Composition, Knowledge, Attitude, Practice.



1. INTRODUCTION

Nowadays, more non-communicable diseases (NCDs) prevail than communicable diseases (CDs). Altering patterns of consumption, living standards and aging population are linked with an increased prominence of diseases such as cancers, heart disease, stroke, mental illness, diabetes and other conditions linked to obesity [1]. There is a growing prevalence of NCDs in emerging economies associated with unhealthy modern lifestyles (unhealthy diet, physical inactivity, smoking and the consumption of alcohol) affecting the socio-economic development [2].

In 2015, 17 million premature deaths (under the age of 70) were caused by NCDs, of which 82% were in low- and middle-income countries, and 37% were caused by Cardiovascular Diseases (CVD) [3]. Similarly, in South East Asia, many types of CVDs reported a quarter of all deaths annually. NCDs in Thailand are estimated to account for 74% of all deaths. Proportional mortality of CVDs is around 23% in 399,100 people [4].

Dyslipidemia is the main sign associated with CVDs which is one of the major NCDs. Body composition is also one of the key health status criteria relevant to individuals. The most significant change in body composition is associated with the metabolism system, and in this context, it is linked with dyslipidemia. According to the Thailand health report in 2013, Thai people partook in exercise less frequently, consumed more sweet, oily, and salty food and ate fewer vegetables and fruits, whilst smoking and drinking more alcoholic beverages. This lifestyle being conducive to CVDs/ Diabetes Miletus (DM) [5]].The prevalence of Thai dyslipidemia was found to be 40.2% in women and 30.1% in men, respectively, while a hospital in Thailand reported the prevalence of dyslipidemia in hospital staff during the year 2008-2011 to be 66.5%, 60.3%, 63.4%, 61.5%, respectively [6]. The improvement in dyslipidemia management among healthcare workers will not only benefit themselves but also patients.

Recent advances in information technology (IT) have in turn led to advances in the management of patients, and especially elderly patients with chronic illnesses [7]. There were some studies which have shown the effectiveness of these technologies especially mobile health (m-health) interventions such as smartphone, mobile phone, short message service (SMS) and mobile application on health-related behaviour promoting healthy lifestyle [8]. Therefore, M-Health applications are a means of communicating, collecting patient information and monitoring self-care. This study aims to explore the effect of “CHICKEN LOF”: M-health application on lipid profile and body composition among healthcare workers with dyslipidemia as a communication channel to improve their knowledge, attitude and practice (KAP) of lipid profile and body composition.

2. MATERIALS AND METHODS

2.1. Study Participants and Area

This study was conducted among fulltime healthcare workers having dyslipidemia from Phuket City Hospital, Thailand. It is the first administrative organization hospital and run by the Phuket administrative organization. According to data collected by the hospital, there were a total of 328 full-time staff (physicians not included) with 129 out of 220 staff being monitored showing an abnormal lipid profile during their health check-ups in 2018. The inclusion criteria of the study participants were as follows: 1) Full-time healthcare worker (age 20-55 years old) who had at least one-year working experience at the study hospital, 2) Had taken a lipid profile test in 2018 and had at least one abnormal lipid profile in their result, 3) No clinical symptoms and significant change in body weight in last 12 months, and 4) Having smartphone and internet access. The abnormal lipid profile in this study accounted for total Cholesterol more than 200 mg/dL and/or LDL Cholesterol more than 100 mg/dL and/or HDL Cholesterol Level less than 60 mg/dL and/or Triglyceride Level more than 150 mg/dL. Participants with pregnancy or planned pregnancy within 3 months of this trial were excluded from this study and participants who received new medicines for lipid profile lowering after starting the program were excluded from this study.

2.2. Study Design and Sample Size

This study was a randomized controlled trial. The sample size was calculated by G*power 3.1.5 program. After adding a 10% drop-out and consideration for type II error, the final size for each group was 40, and the total sample size for this study was 80 full-time healthcare workers with dyslipidemia. Then, participants were randomly assigned by a computer generator into 2 groups (intervention and control). The participants were blinded when given treatment. The intervention group received “CHICKEN LOF”: M-Health Application and usual care. The control group received only usual care. Both groups were homogeneity tested to confirm the similarity between the 2 groups. The methodology “Intention to Treat Analysis” was used; the following flow chart is shown in Fig. (1).

A total of 4 serial measurements were done at day 0 (baseline), 30, 60 and 90. A self-administered questionnaire was used and there were 3 parts of the instruments as follows;

  1. Characteristics and lifestyle effects on health including general characteristics of the participants (age, gender, night shift (hours/ week), smoking and alcohol consumption) and lifestyle-related activities (dietary habits, exercise, hours of sleep, vitamin D intake, water consumption and job stress).
  2. Knowledge Attitude and Practice. In the Knowledge part of the assessment, a total of 19 statements were included and scored “1” point for “True”, and “0” point for “False”, “Do not know” and “Incorrect” answers. The total score varied from 0 to 19. A total of 16 statements were included and Likert scale was used: “5” points for “Strongly Disagree (SD)”, “4” points for “Disagree (D)”, “3” points for “Neutral (N)”, “2” points for “Agree (A)” and “1” point for “Strongly Agree (SA)” for all “Negative” statements while reverse scoring of 1 point to 5 points was for all “Positive” statements. The total score varied from 16 to 80. In the Practice part, there were a total of 20 statements and scored “1” point for “Always”, “2” points for “Sometimes” and “3” points for “Never” for all “Negative” statements and reverse scoring for all “Positive” statements. The total score varied from 20 to 60. The knowledge score was divided into 1 point, attitude score was divided into 5 points and the practice score was divided into 4 points.
  3. Record list of Lipid Profile and Body Composition. Lipid Profile was completed by the hospital blood department and it included TC (mg/dL), HDL-C (mg/dL), TG (mg/dL), and LDL-C (mg/dL). Results were required to be reported to the researcher and assistants within 7days after the test. The “TANITA model BC-731: Body Composition Monitor” from the hospital was used as a tool of assessment for body composition and it measured Waist(cm), Hip (cm), BMI (kg/m2), Body fat mass (kg), Body fat percentage (%), Fat free mass (kg), Skeletal muscle mass (kg), Visceral fat level, Waist-Hip ratio, and Basal metabolic rate (kcal). All blood samples were destroyed according to proper hospital procedures after results were attained.

2.4. Outcomes

The primary outcome of this present study was to compare the change of KAP of lipid profile and body composition modifying within and between groups at day 30, 60, 90 and baseline. The secondary outcomes were to compare the change of lipid profile and body composition within and between groups at day 30, 60, 90 and baseline.

2.5. Intervention and Setting

The “CHICKEN LOF” application was developed from a board game for this study with the players (users) being representative of themselves. This application has both English and Thai versions. There are 6 modes in the application. They are as follows; a walk in the sun, be happy, calm and sleep, drink more water, exercise daily, and food control. This application was installed directly into each of the personal mobile phones of participants as it cannot be downloaded online. The user interface of the Chicken LOF mobile application is shown in Fig. (2).

Fig. (1). Flow chart of the study

Fig. (2). User Interface of CHICKEN LOF mobile application.

The participants from the control group did not receive this application. Both the control group and intervention group received usual care which included general consultation by the physician in the hospital regarding diet and exercise after blood testing.

2.6. Statistical Analysis

The present study used SPSS version 22 for data analysis and homogeneity of baseline characteristics was analysed by using Independent t-test for nominal data and Chi-square test for categorical data. For inferential statistics, One-Way ANOVA Repeated Measurement was used for comparison of all time points within groups for both the intervention group and the control group. The pairwise comparison of One-Way ANOVA Repeated Measurement was done for the intervention group at different times of measurement. The Independent t-test was used to compare the change between the intervention group and the control group for all time points. The level of significance was set at p < 0.05 for all statistical analyses.

3. RESULTS

The mean age of the intervention group was 33.9 years and that of the control group was 33.2 years. Most of the participants were females (29 participants in the intervention group and 33 participants in the control group). Both groups had a night shift of approximately 10 hours/week. About half of the participants from each group had job stress and more than half of the participants slept less than 7 hours. In both groups, no daily cholesterol/ calories control (32 participants in the intervention and 29 participants in control) and no daily exercise (38 participants in the intervention and 35 participants in control) were found. All of the baseline characteristics showed no statistically significant difference between the intervention group and the control group.

The statistically significant differences between the intervention group and the control group were found in terms of total knowledge (p=0.002 on day 60 and p=0.003 at day 90), total attitude (p=0.009 on day 60 and p=0.001 at day 90), HDL-C (p=0.049 at day 90) and LDL-C (p=0.048 at day 90).

Table 1 shows the modifiying total knowledge, attitude and practice regarding lipid and body composition within groups at baseline, day 30, 60 and 90. All of the participants in the intervention group showed statistically significant differences in the mean score of total knowledge, attitude and practice (P< 0.001, p= 0.001 and p< 0.001 respectively).

The change of lipid profile within groups at baseline, day 30, 60 and 90 is shown in Table 2. Only TG (mg/dl) showed statistically significant changes in mean score within the intervention group (p= 0.002).

Table 3 shows the change in body composition within groups at baseline, day30, 60 and 90. Among all variables of body composition, the following variables showed statistically significant changes in the intervention group: weight (Kg), BMI (kg/m2), Body fat percentage (%), bone mass, BMR, Total Body Water (%) (p< 0.001, p= 0.001, p= 0.029, p= 0.030, p= 0.032 and p= 0.027, respectively.

Pairwise comparison of knowledge, attitude, practice, lipid profile and body composition within the intervention group at baseline, day 30, 60 and 90 is shown in Table 4 and Table 5. In KAP, there were statistically significant mean differences between baseline and at day 30, 60 and 90. In the lipid profile of HDL-C (mg/dl), statistically significant mean differences were found between baseline and day 60, and between day 30 and 90. In BMI (kg/m2), all time points showed statistically significant mean differences except between day 30 and 60, and between day 60 and 90.

Within-group comparison by using one-way anova repeated measure

Table 1. Changes in total knowledge, attitude and practice of lipid and body composition modifying score within groups at baseline, day30, 60 and 90
KAP Group Source Sum of
Squares
df Mean
Squares
F P value
Knowledge Total Intervention Time (Baseline, Day30, 60, 90) .377 3 .126 7.573 <.001*
Error (Time) 1.942 117 .017
Control Time (Baseline, Day30, 60, 90) .015 3 .005 .221 .882
Error (Time) 2.406 108 .022
Attitude Total Intervention Time (Baseline, Day30, 60, 90) 2.459 3 .820 6.306 .001*
Error (Time) 15.206 117 .130
Control Time (Baseline, Day30, 60, 90) .113 3 .038 .242 .867
Error (Time) 16.827 108 .156
Practice Total Intervention Time (Baseline, Day30, 60, 90) .610 3 .203 7.339 <.001*
Error (Time) 3.244 117 .028
Control Time (Baseline, Day30, 60, 90) .040 3 .013 .410 .746
Error (Time) 3.543 108 .033
*Significant at p < 0.05
Table 2. Changes in lipid profile within groups at baseline, day30, 60 and 90
Lipid profile Group Source Sum of
Squares
df Mean
Squares
F P-value
TC (mg/dL) Intervention Time (Baseline, Day30, 60, 90) 2363.619 3 787.873 1.650 .182
Error (Time) 55871.131 117 477.531
Control Time (Baseline, Day30, 60, 90) 657.378 3 219.126 .560 .643
Error (Time) 42297.122 108 391.640
TG (mg/dL) Intervention Time (Baseline, Day30, 60, 90) 1729.350 3 576.450 .380 .768
Error (Time) 177443.150 117 1516.608
Control Time (Baseline, Day30, 60, 90) 1589.750 3 529.917 .120 .948
Error (Time) 478205.500 108 4427.829
HDL-C (mg/dL) Intervention Time (Baseline, Day30, 60, 90) 498.669 3 166.223 5.201 .002*
Error (Time) 3739.581 117 31.962
Control Time (Baseline, Day30, 60, 90) 194.831 3 64.944 2.258 .086
Error (Time) 3105.919 108 28.759
LDL-C (mg/dL) Intervention Time (Baseline, Day30, 60, 90) 374.075 3 124.692 .143 .934
Error (Time) 102368.925 117 874.948
Control Time (Baseline, Day30, 60, 90) 5519.101 3 1839.700 .870 .459
Error (Time) 228315.149 108 2114.029
*Significant at p < 0.05
Table 3. Changes in body composition within groups at baseline, day30, 60 and 90
Body composition Group Source Sum of
Squares
df Mean
Squares
F P-value
Weight (Kg.) Intervention Time (Baseline, Day30, 60, 90) 54.321 3 18.107 8.007 <.001*
Error (Time) 264.599 117 2.262
Control Time (Baseline, Day30, 60, 90) 3.753 3 1.251 .524 .666
Error (Time) 257.620 108 2.385
BMI (kg/m2) Intervention Time (Baseline, Day30, 60, 90) 16.090 3 5.363 5.713 .001*
Error (Time) 109.847 117 .939
Control Time (Baseline, Day30, 60, 90) 3.417 3 1.139 .783 .506
Error (Time) 157.168 108 1.455
Body fat percentage (%) Intervention Time (Baseline, Day30, 60, 90) 208.221 3 69.407 3.123 .029*
Error (Time) 2600.246 117 22.224
Control Time (Baseline, Day30, 60, 90) 21.290 3 7.097 1.051 .373
Error (Time) 729.298 108 6.753
Visceral Fat Level Intervention Time (Baseline, Day30, 60, 90) .389 3 .130 .331 .803
Error (Time) 45.856 117 .392
Control Time (Baseline, Day30, 60, 90) .056 3 .019 .025 .995
Error (Time) 80.487 108 .745
Muscle Mass (kg) Intervention Time (Baseline, Day30, 60, 90) 8.926 3 2.975 1.799 .151
Error (Time) 193.457 117 1.653
Control Time (Baseline, Day30, 60, 90) 10.925 3 3.642 .885 .451
Error (Time) 444.172 108 4.113
Physique Rating Intervention Time (Baseline, Day30, 60, 90) 1.092 3 .364 1.030 .382
Error (Time) 41.345 117 .353
Control Time (Baseline, Day30, 60, 90) .541 3 .180 .314 .815
Error (Time) 61.959 108 .574
Bone Mass Intervention Time (Baseline, Day30, 60, 90) .217 3 .072 3.089 .030*
Error (Time) 2.743 117 .023
Control Time (Baseline, Day30, 60, 90) .029 3 .010 1.050 .374
Error (Time) 1.008 108 .009
BMR Intervention Time (Baseline, Day30, 60, 90) 22141.925 3 7380.642 3.037 .032*
Error (Time) 284355.075 117 2430.385
Control Time (Baseline, Day30, 60, 90) 11687.486 3 3895.829 1.364 .258
Error (Time) 308572.514 108 2857.153
Metabolic Age Intervention Time (Baseline, Day30, 60, 90) 29.300 3 9.767 1.215 .307
Error (Time) 940.200 117 8.036
Control Time (Baseline, Day30, 60, 90) 141.243 3 47.081 1.445 .234
Error (Time) 3518.257 108 32.576
Total Body Water (%) Intervention Time (Baseline, Day30, 60, 90) 15.109 3 5.036 3.172 .027*
Error (Time) 185.756 117 1.588
Control Time (Baseline, Day30, 60, 90) .052 3 .017 .007 .999
Error (Time) 256.580 108 2.376
Waist-Hip Ratio Intervention Time (Baseline, Day30, 60, 90) .014 3 .005 1.834 .145
Error (Time) .295 117 .003
Control Time (Baseline, Day30, 60, 90) .004 3 .001 .832 .479
Error (Time) .179 108 .002
*Significant at p < 0.05
Table 4. Pairwise comparison of knowledge, attitude and practice within intervention group at baseline, day 30, 60 and 90
Variable Group Time Mean difference Std.Error P-value 95%CI for difference
Lower bound Upper bound
Knowledge
Total
Intervention Baseline-Day30 -0.069 .022 .003* -0.113 -0.025
Baseline-Day60 -0.102 .031 .002* -0.164 -0.040
Baseline-Day90 -0.130 .040 .002* -0.210 -0.050
Day30-Day60 -0.033 .023 .167 -0.080 .014
Day30-Day90 -0.061 .029 .041* -0.120 -0.003
Day60-Day90 .028 .024 .251 -0.078 .021
Attitude
Total
Intervention Baseline-Day30 -0.185 .086 .039* -0.359 -0.10
Baseline-Day60 -0.231 .100 .026* -0.433 -0.030
Baseline-Day90 -0.344 .097 .001* -0.541 -0.147
Day30-Day60 -0.047 .060 .442 -0.168 .075
Day30-Day90 -0.159 .063 .016* -0.286 -0.032
Day60-Day90 -0.112 .068 .104 -0.249 .024
Practice
Total
Intervention Baseline-Day30 -0.084 .035 .020* -0.154 -0.014
Baseline-Day60 -0.160 .041 <0.001* -0.242 -0.078
Baseline-Day90 -0.139 .036 <0.001* -0.212 -0.066
Day30-Day60 -0.076 .040 .068 -0.157 .006
Day30-Day90 -0.055 .034 .116 -0.124 .014
Day60-Day90 .021 .037 .579 -0.054 .096
*Significant at p < 0.05
Table 5. Pairwise comparison of lipid profile and body composition within the intervention group at baseline, day 30, 60 and 90
Variables Group Time Mean difference Std.Error P-value 95%CI for difference
Lower bound Upper bound
Lipid profile
HDL-C Intervention Baseline-Day30 -2.000 1.210 .106 -4.447 .447
(mg/dL) Baseline-Day60 3.250 1.591 .048* -6.468 -0.032
Baseline-Day90 -4.825 1.189 <0.001* -7.229 -2.421
Day30-Day60 -1.250 1.028 .231 -3.330 .830
Day30-Day90 -2.825 1.251 .030* -5.356 -0.294
Day60-Day90 -1.575 1.248 .214 -4.099 .949
Body composition
Weight Intervention Baseline-Day30 .448 .233 .063 -0.025 .920
(Kg.) Baseline-Day60 .960 .396 .020* .159 1.761
Baseline-Day90 1.563 .398 .000* .758 2.367
Day30-Day60 .512 .288 .083 -0.070 1.095
Day30-Day90 1.115 .371 .005* .364 1.866
Day60-Day90 .602 .297 .049* .002 1.203
BMI Intervention Baseline-Day30 .265 .129 .047* .004 .526
(kg/m2) Baseline-Day60 .653 .269 .020* .109 1.196
Baseline-Day90 .805 .262 .004* .276 1.334
Day30-Day60 .387 .231 .102 -0.080 .855
Day30-Day90 .540 .242 .031* .051 1.029
Day60-Day90 .152 .112 .181 -0.074 .379
Body fat Intervention Baseline-Day30 .195 1.406 .890 -2.650 3.040
percentage Baseline-Day60 1.208 .698 .092 -0.205 2.620
(%) Baseline-Day90 2.880 .880 .002* 1.101 4.659
Day30-Day60 1.012 1.249 .422 -1.513 3.538
Day30-Day90 2.685 1.264 .040* .128 5.242
Day60-Day90 1.672 .520 .003* .622 2.723
Bone Mass Intervention Baseline-Day30 .055 .036 .131 -0.017 .127
Baseline-Day60 .088 .043 .051 .000 .175
Baseline-Day90 .093 .042 .035* .007 .178
Day30-Day60 .032 .030 .286 -0.028 .093
Day30-Day90 .037 .031 .227 -0.024 .099
Day60-Day90 .005 .016 .750 -0.027 .037
BMR Intervention Baseline-Day30 11.475 4.356 .012* 2.664 20.286
Baseline-Day60 25.625 13.039 .057 -0.749 51.999
Baseline-Day90 29.650 13.017 .028* 3.320 55.980
Day30-Day60 14.150 12.729 .273 -11.596 39.896
Day30-Day90 18.175 13.160 .175 -8.443 44.793
Day60-Day90 4.025 5.955 .503 -8.021 16.071
Total Body Water (%) Intervention Baseline-Day30 -0.107 .168 .527 -0.448 .233
Baseline-Day60 -0.387 .294 .195 -0.981 .206
Baseline-Day90 -0.795 .368 .037* -1.539 -0.051
Day30-Day60 -0.280 .225 .221 -0.735 .175
Day30-Day90 -0.688 .315 .035* -1.325 -0.050
Day60-Day90 -0.408 .277 .149 -0.967 .152
*Significant at p < 0.05

4. DISCUSSION

In this study, it was found that the CHICKEN LOF (M-Health application) had positive effects on total knowledge, attitude and practice of lipid and body composition, lipid profile (HDL-C) and body composition (Weight, BMI, Body Fat percentage, Bone Mass, BMR and Total Body Water percentage) among healthcare workers in Phuket City hospital. In a systematic review study on mobile phone interventions to increase physical activity and reduce weight, it was pointed out that all technology interventions including mobile phone applications with health education components are effective for physical activity and weight reduction [9]. This current CHICKEN LOF application supports users (participants) in their accountability or self-monitoring for healthy lifestyle [10]. This is supported by a systematic review study on mobile phone intervention for facilitating self-management of long term illness in which m-Health proved to be useful for self-monitoring and self-management [11].

The intervention group had shown that there was statistically significant mean difference in knowledge, attitude and practice in the intervention group compared to the control group. Increased means of total knowledge, attitude and practice of lipid profile and body composition at day 30, 60 and 90 compared to baseline were found. It can be stated that this study using m-Health intervention was useful in improving health knowledge and attitude and practice for self-management of metabolic disorders such as obesity and diabetes. The findings accord with another study on translating exercise intentions into behaviour [12].

Although it is important to reduce LDL-C in the lipid profile to treat dyslipidemia, there was no significant change in the reduction of LDL-C within the intervention group in this study [13]. This result is in contrast with the study on the efficacy of combined strategy for hypercholesterolemia patients that there was a reduction in LDL-C [14]. It can be related to those participants who had night shift load, that the cumulative and annual incidence of metabolic syndrome is higher among night-shift healthcare workers than day-shift healthcare workers (2.9% versus 0.5%) [15]. Among lipid profiles, HDL-C (mg/dl) in the intervention group showed a significant mean difference between baseline and day 90, and between day 30 and 90 with a positive effect.

The participants in the intervention group presented a significant change in body composition (Weight, BMI, Body Fat percentage, Bone Mass, BMR, Total Body Water) compared to the control group. The weight and BMI of participants in the intervention group increased from baseline to day 30, 60 and 90 and this result is in contrast with the study on the effect of lifestyle modification using the smartphone application which might be due to different participants of studies (healthcare workers versus patients) [16]. This result is also in contrast with the study on the efficacy of smartphone-based weight loss intervention [17]. It might be due to a short-term lifestyle modification by using a mobile phone application; however, this did not have a significant impact but it is feasible and more effective than other interventions and low and middle-income countries can easily apply this intervention. In another study on the effectiveness of smartphone application for weight loss, there was no increased weight loss compared to the control group and it might be related to lack of motivation of the participants to lose weight and/or lack of self-monitoring regarding their diet and physical activity. Therefore, it is required to question participants regarding their intention, interest, motivation and whether they have a goal in mind to lose weight in the screening process of the study [18].

There are some limitations in the present study. The study was conducted for only 90 days whilst there can be more reduction and changes in both the lipid profile and body composition in long term implementation. The participants of this present study were healthcare workers and had medical/ health knowledge, so there may be generalization of outcomes.

CONCLUSION

This present study has shown a positive effect of M-Health application: CHICKEN LOF on lipid and body composition among healthcare workers with dyslipidaemia. It is also feasible to apply for self-monitoring of healthy lifestyles in the community especially in low and middle-income countries. Further studies with longer implementation periods are recommended for the sustainable effect of M-health interventions. Policymakers should include this Chicken LOF mobile application in the policies once a longer duration research had shown effectiveness, and it should be applied in primary care settings.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

The ethical approval of this study was taken from the Research Ethics Review Committee for Research Involving Human Research Participants, Health Sciences Group, Chulalongkorn University, Thailand (COA no. 249/2019).

HUMAN AND ANIMAL RIGHTS

No animals were used in this research. All human research procedures followed were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national), and with the Helsinki Declaration of 1975, as revised in 2013.

CONSENT FOR PUBLICATION

This study took informed and written consent from all participants. Participants were informed regarding the purpose of the study including usage and publication of data, anonymity, confidentiality and freedom to participate and withdraw.

AVAILABILITY OF DATA MATERIALS

The data supporting the findings of the article is available in the SuwadeePuntpanich at suwadeepuntpanich@gmail.com with the reference “COA 249/2019”.

FUNDING

None.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

The authors thank the management team, all supporting staff and the participants (healthcare workers) of the Phuket City Hospital.

REFERENCES

[1] World Health Organization. WHO CVD Risk Management Package for low and medium resource settings. WHO; 2002 [cited 2020 Jan 15]. Available from: https://apps. who.int/ iris/bitstream/handle/10665/42621/9241545852.pdf;jsessionid=9437ABA8EFF7CC94C552990A9DB2FCAF?sequence=1
[2] Reubi D, Herrick C, Brown T. The politics of non-communicable diseases in the global South. Health Place 2016; 39: 179-87.
[3] Regional Office for South-East Asia. The Decade for Health Workforce Strengthening in the SEA Region 2015-2024: First review of progress challenges and opportunities. WHO; 2016 [cited 2020 Jan 15]. Available from: https://apps.who.int/iris/handle/10665/246273
[4] World Health Organization. Noncommunicable Disease (NCD) Country Profiles, Thailand. WHO; 2018 [cited 2020 Jan 18]. Available from: https://www.google.com/url?sa=t&rct= j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwjTwb6O0M7nAhUEzjgGHT8eD-EQFjAAegQIAxAB&url=https%3A%2F%2Fwww.who.int%2Fnmh%2Fcountries%2Ftha_en.pdf
[5] 5. Thai Health Promotion Foundation. Thai Health Report; 2013 [cited 2020 Jan 18]. Available from: https://en.thaihealth.or.th /RESOURCE_CENTER.html
[6] Chanpol K, Tanavikrankoon M. Prevalence and associated factors of dyslipidemia in personnel at Rajavithi Hospital Medicine Health Journal 2015.
[7] Seo WK, Kang J, Jeon M, et al. Feasibility of using a mobile application for the monitoring and management of stroke-associated risk factors. J Clin Neurol 2015; 11(2): 142-8.
[8] Han M, Lee E. Effectiveness of Mobile Health Application Use to Improve Health Behavior Changes: A Systematic Review of Randomized Controlled Trials. Healthc Inform Res 2018; 24(3): 207-26.
[9] Stephens J, Allen J. Mobile phone interventions to increase physical activity and reduce weight: a systematic review. J Cardiovasc Nurs 2013; 28(4): 320-9.
[10] Mohr DC, Cuijpers P, Lehman K. Supportive accountability: a model for providing human support to enhance adherence to eHealth interventions. J Med Internet Res 2011; 13(1)e30
[11] de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev 2012; 12CD007459
[12] Rhodes RE, Courneya KS, Jones LW. Translating exercise intentions into behavior: personality and social cognitive correlates. J Health Psychol 2003; 8(4): 447-58.
[13] Reiner Z, Catapano AL, De Backer G, et al. European association for cardiovascular prevention & rehabilitation; esc committee for practice guidelines (cpg) 2008-2010 and 2010-2012 committees. esc/eas guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the european society of cardiology (esc) and the european atherosclerosis society (eas). Eur Heart J 2011; 32(14): 1769-818.
[14] Párraga-Martínez I, Escobar-Rabadán F, Rabanales-Sotos J, et al. Efficacy of a combined strategy to improve low-density lipoprotein cholesterol control among patients with hypercholesterolemia: a randomized clinical trial. Rev Esp Cardiol (Engl Ed) 2018; 71(1): 33-41.
[15] Pietroiusti A, Neri A, Somma G, et al. Incidence of metabolic syndrome among night-shift healthcare workers. Occup Environ Med 2010; 67(1): 54-7.
[16] Cho SW, Wee JH, Yoo S, et al. Effect of lifestyle modification using a smartphone application on obesity with obstructive sleep apnea: a short-term, randomized controlled study. Clin Exp Otorhinolaryngol 2018; 11(3): 192-8.
[17] Martin CK, Miller AC, Thomas DM, Champagne CM, Han H, Church T. Efficacy of SmartLoss, a smartphone-based weight loss intervention: results from a randomized controlled trial. Obesity (Silver Spring) 2015; 23(5): 935-42.
[18] Laing BY, Mangione CM, Tseng CH, et al. Effectiveness of a smartphone application for weight loss compared with usual care in overweight primary care patients: a randomized, controlled trial. Ann Intern Med 2014; 161(10)(Suppl.): S5-S12.